Paragon Biosciences is a global development and biopharmaceutical investment firm with offices located in Chicago, Philadelphia, and New Jersey. The firm works diligently to assist innovative pharmaceutical and medical research companies in creating crucial, breakthrough medicines for patients. These companies share Paragon’s goal of delivering better outcomes to the healthcare industry. This task, though, takes diligence, vision, and leadership, which doesn’t stretch thin under Paragon’s management.
As the chairman and CEO of Paragon Biosciences, Jeff Aronin continues to uphold and enforce Paragon’s mission. Formerly the president and chief executive of Ovation Pharmaceuticals Inc., Jeff has used his vast management and operations experience to bring business development skills, strategy, and leadership to the day-to-day operations of Paragon.
The management team, under Jeff’s leadership, are committed to continual scientific discovery. In fact, the team has earned 13 FDA drug approvals over the last ten years, a feat typically only achieved by much larger companies. Such groundbreaking work requires not only the highest grade of scientific inquest and equipment, but also rigorous dedication to serving patients. Paragon values the needs of patients above all, using its expertise to tirelessly identify, finance, and develop biotech companies working to uncover critical scientific breakthroughs.
Jeff Aronin from Paragon provides these client companies with a variety of resources necessary for success, such as cutting-edge physical resources, highly credible clinical experts, and savvy entrepreneurs. By pairing companies with the top names in the field, Paragon empowers multiple players to join forces to discuss strategy and support and guide each other. Together, these portfolio companies, experts, and top medical professionals conduct all phases of study, research, drug development, clinical trials, reassessment, and recommendation to create the important medicines that patients desperately need (http://alivenewspaper.com/2018/02/jeff-aronin-paragon-biosciences/). With relentless vigor, speed, and efficiency, the team at Paragon Biosciences continues to bring the most novel, yet necessary, medications to patients in need.